−1.21SEK
−116.07 MSEK
546.00 KSEK
87.47 M
About DIAMYD MEDICAL AB SER. B
Sector
CEO
Ulf Hannelius
Headquarters
Stockholm
Website
Employees (FY)
25
Founded
1984
ISIN
SE0005162880
FIGI
BBG004DD90Y1
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. It also develops and invests in stem cell and medical technology. The company was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DMYD_B is 9.80 SEK — it has decreased by 0.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange DIAMYD MEDICAL AB SER. B stocks are traded under the ticker DMYD_B.
DMYD_B stock is 7.32% volatile and has beta coefficient of 0.98. Check out the list of the most volatile stocks — is DIAMYD MEDICAL AB SER. B there?
Yes, you can track DIAMYD MEDICAL AB SER. B financials in yearly and quarterly reports right on TradingView.
DMYD_B stock hasn't changed in a week, the month change is a 12.50% fall, over the last year DIAMYD MEDICAL AB SER. B has showed a 48.42% decrease.
DMYD_B net income for the last quarter is −29.25 M SEK, while the quarter before that showed −32.78 M SEK of net income which accounts for 10.77% change. Track more DIAMYD MEDICAL AB SER. B financial stats to get the full picture.
Today DIAMYD MEDICAL AB SER. B has the market capitalization of 1.02 B, it has decreased by 0.20% over the last week.
No, DMYD_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DMYD_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIAMYD MEDICAL AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 25.00 employees. See our rating of the largest employees — is DIAMYD MEDICAL AB SER. B on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIAMYD MEDICAL AB SER. B technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIAMYD MEDICAL AB SER. B stock shows the sell signal. See more of DIAMYD MEDICAL AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIAMYD MEDICAL AB SER. B EBITDA is −116.20 M SEK, and current EBITDA margin is −20.64 K%. See more stats in DIAMYD MEDICAL AB SER. B financial statements.